Michael D. Tharp

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 621 citations · Full text

Cutaneous T-cell Lymphoma, Lymphoid Neoplasia, Medicine +6

Activating and dominant inactivating c-<i>KIT</i>catalytic domain mutations in distinct clinical forms of human mastocytosis

B. Jack Longley, Dean D. Metcalfe, Michael D. Tharp et al. · Proceedings of the National Academy of Sciences · 1999 · 553 citations · Full text

A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss

Anne W. Lucky, Daniel Piacquadio, Chérie M. Ditre et al. · Journal of the American Academy of Dermatology · 2004 · 294 citations

Gynecology, Placebo-controlled Trial, Skin Pharmacology +2

Conjugated avidin binds to mast cell granules.

Michael D. Tharp, Leonard L. Seelig, R E Tigelaar et al. · Journal of Histochemistry & Cytochemistry · 1985 · 159 citations

Immunocytochemical Technique, Mast Cell Disorder, Immunology +20

Mast Cell and Myofibroblast in Wound Healing

Patricia A. Hebda, Margaret Collins, Michael D. Tharp · Dermatologic Clinics · 1993 · 139 citations

Wound Care, Wound Healing, Mast Cell +4